iSpheric gains US approval

Article

The iSpheric Model YA-60BB intraocular lens (IOL) (Hoya) has received FDA approval.

The iSpheric Model YA-60BB intraocular lens (IOL) (Hoya) has received FDA approval.

The foldable hydrophobic IOL, which is already available in Europe and Asia, features a blue-light blocker and can be implanted through an un-enlarged incision. In a clinical trial, 98% of the 600 enrolled subjects reported best corrected visual acuity (BCVA) of ≥20/40 from one-month postoperatively until the final 12-month follow-up visit. No significant adverse events were reported.

The iSpheric will have its official launch at this year's American Academy of Ophthalmology (AAO) meeting, which will be held November 8–11 in Atlanta, GA, US. The lens will be shipped to facilities in the US by the end of the year, and a new version, available in the iSert pre-loaded injector system, will be available in early 2009.

Related Videos
Ms Neeru Vallabh on a virtual call with Ophthalmology Times Europe
A screenshot of Dr Filomena Ribeiro, president of the ESCRS
Ramin Tadayoni, MD, speaks with Sheryl Stevenson
Jennifer I. Lim, MD, FARVO, FASRS, Director of Retina Service, University of Illinois at Chicago
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center
Carl D. Regillo, MD, FACS, FASRS, Chief of Retina Service, Wills Eye Hospital, Philadelphia, PA
Arshad Khanani, MD, MA FASRS, on a virtual call
© 2024 MJH Life Sciences

All rights reserved.